A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD

NCT06309277 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Gilgamesh Pharmaceuticals